• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Puma Biotechnology Inc - Common Stock (NQ:PBYI)

    4.840 +0.140 (+2.98%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 635,413
    Open 4.740
    Bid (Size) 4.810 (5)
    Ask (Size) 4.920 (1)
    Prev. Close 4.700
    Today's Range 4.710 - 4.920
    52wk Range 2.320 - 6.070
    Shares Outstanding 47,509,765
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference
    From Puma Biotechnology, Inc.
    Via Business Wire

    Performance

    YTD
    +55.1%
    +55.1%
    1 Month
    -6.6%
    -6.6%
    3 Month
    +46.2%
    +46.2%
    6 Month
    +53.7%
    +53.7%
    1 Year
    +89.8%
    +89.8%

    More News

    Read More
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    Earnings Scheduled For August 7, 2025
    Via Benzinga
    Earnings Scheduled For May 8, 2025
    Via Benzinga
    Earnings Scheduled For February 27, 2025
    Via Benzinga
    Puma (PBYI) Q2 Revenue Rises 11%
    Via The Motley Fool
    Topics Intellectual Property
    Puma Biotechnology Reports Second Quarter Financial Results
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology Reports First Quarter Financial Results
    From Puma Biotechnology, Inc..
    Via Business Wire
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology to Present at TD Cowen’s 45th Annual Health Care Conference
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    From Puma Biotechnology, Inc.
    Via Business Wire
    Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation
    From Puma Biotechnology, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Puma Biotechnology Inc - Common Stock publicly traded?
    Yes, Puma Biotechnology Inc - Common Stock is publicly traded.
    What exchange does Puma Biotechnology Inc - Common Stock trade on?
    Puma Biotechnology Inc - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Puma Biotechnology Inc - Common Stock?
    The ticker symbol for Puma Biotechnology Inc - Common Stock is PBYI on the Nasdaq Stock Market
    What is the current price of Puma Biotechnology Inc - Common Stock?
    The current price of Puma Biotechnology Inc - Common Stock is 4.840
    When was Puma Biotechnology Inc - Common Stock last traded?
    The last trade of Puma Biotechnology Inc - Common Stock was at 09/26/25 04:00 PM ET
    What is the market capitalization of Puma Biotechnology Inc - Common Stock?
    The market capitalization of Puma Biotechnology Inc - Common Stock is 229.95M
    How many shares of Puma Biotechnology Inc - Common Stock are outstanding?
    Puma Biotechnology Inc - Common Stock has 230M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.